Lymphoma, T-Cell, Cutaneous

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)

Recruiting
  • Lymphoma, T-Cell, Peripheral
  • +4 more
  • MT-101
  • MT-101 + Conditioning (Lymphodepleting) Chemotherapy
  • Duarte, California
  • +8 more
Jan 27, 2023

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,

Terminated
  • Mycosis Fungoides
  • +2 more
  • Naloxone Hydrochloride Lotion, 0.5%
  • Placebo Lotion
  • Little Rock, Arkansas
  • +15 more
Oct 26, 2022

Disease, Hodgkin, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Non-Hodgkin Trial in Worldwide (brentuximab vedotin)

No longer available
  • Disease, Hodgkin
  • +3 more
  • brentuximab vedotin
  • Stanford, California
  • +30 more
Sep 17, 2020

Hodgkin Disease, Lymphoma, Large-Cell, Sarcoma, Kaposi Trial in United States (SGN-30 (mAb))

Completed
  • Hodgkin Disease
  • +4 more
  • SGN-30 (monoclonal antibody)
  • Birmingham, Alabama
  • +9 more
Oct 7, 2011

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides, Sezary Syndrome Trial in Worldwide (ONTAK)

Completed
  • Lymphoma, T-Cell, Cutaneous
  • +2 more
  • Houston, Texas
  • +34 more
Feb 29, 2008

Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides, Sezary Syndrome Trial in Worldwide (ONTAK)

Completed
  • Lymphoma, T-Cell, Cutaneous
  • +2 more
  • Houston, Texas
  • +33 more
Feb 29, 2008